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We examined plasma from macaques infected with three different phenotypes of SIVmac for their ability to neutralize the
infectivity of homologous and heterologous virus in lymphocyte (CEMx174 cells or normal rhesus macaque peripheral blood
lymphocytes) or normal rhesus macaque macrophage (Mf) cultures. Similar to previous findings, we observed that some
plasmas failed to neutralize or poorly neutralized the infectivity of SIVmac239 and SIVmac251(1:20 plasma dilution) in
lymphocyte cultures. In contrast, when primary rhesus Mf cultures were used as the indicator cells, the same plasmas
neutralized both viruses at high dilutions (1:200 to 1:20,000). Neutralization of virus infectivity by the various plasmas was
confirmed by SIV core antigen capture assays. We excluded the possibility that this differential neutralization in Mf was
related to the differences in the ability of the virus strain to replicate in these two cell types by demonstrating that the
replication efficiency of SIVmac251 in CEMx174 cells, PBMC, and Mf cultures was very similar. The role of Fc receptors
on the Mf surface in the clearance of the virus–antibody complexes was also excluded since similar neutralizing results
were obtained using whole plasmas, purified IgG antibodies, and purified Fab fragments derived from the IgG fraction of
these plasmas. The mechanism of virus neutralization in Mf does not appear to involve blocking of virus entry into the
cells since radiolabeled virus reacted with anti-SIV antibodies was taken up by rhesus Mf as efficiently as virus reacted
with normal antibody. DNA of the neutralized virus was identified in the Mf cultures, but virus replication, as evidenced
by accumulation of viral protein products, was not detectable so long as the antibodies were present in the medium. Removal
of the antibodies resulted in a resumption of virus replication in the Mf. These results indicate that virus infectivity can
be efficiently neutralized by antibodies in Mf cultures by a mechanism that is fundamentally different from that in lymphocyte
cultures. q 1997 Academic Press
INTRODUCTION the role of infected macrophages in the generation of
the immunodeficient state is poorly understood.
Human immunodeficiency viruses types 1 (HIV-1) and Infected hosts develop several antiviral responses that
2 and simian immunodeficiency virus (SIV) of monkeys restrict replication of the viruses. These responses in-
are the causative agents of an acquired immunodefi- clude cell-mediated responses (antiviral CD8/ T lympho-
ciency syndrome (AIDS) in humans and macaques, re- cytes) and neutralizing antibodies (Poli et al., 1993; Pan-
spectively (Desrosiers, 1990; Letvin and King, 1990; Levy, taleo and Fauci, 1995). However, the clinical relevance
1993; Schnittman and Fauci, 1994). Both of these virus of these neutralizing antibodies in the control of virus
infections result in a gradual loss of CD4/ T lymphocytes, spread following infection remains uncertain. Most stud-
progressive loss of immunological competence, and, ulti- ies on the neutralization of HIV-1 or SIV infectivity by
mately, a fatal immunodeficiency syndrome character- antibodies have been performed using T lymphocyte cell
ized by an increased susceptibility to opportunistic infec- lines (i.e., CEMx174 cells, C8166 cells, etc.) or primary
tions and/or an increased incidence of tumors. In addi- PBMCs as indicator cell type (Burns and Desrosiers,
tion to CD4/ T lymphocytes, these viruses infect cells of 1994; Golding et al., 1994; Kent et al., 1992; Wrin et al.,
the monocyte/macrophage lineage, but while infection of 1995). Previously, we reported that all animals inoculated
this cell type is important in the pathogenesis of lentivi- with either SIVmac239 or the chimeric virus SIVmac239/17E
rus-induced interstitial pneumonia (Travis et al., 1992; developed binding antibodies to both viruses, but that
Anderson and Lee, 1988) or neurological disease (Desro- antibodies induced by either virus rarely neutralized
siers et al., 1991; Price, 1988; Spencer and Price, 1992), SIVmac239 when assays were performed using the
CEMx174 cells as indicator cells (Zhuge et al., 1996). In
this study, we have examined several plasma samples1 To whom correspondence and reprint requests should be ad-
dressed. obtained from macaques infected with different strains
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of SIVmac for their ability to neutralize virus infectivity us- cin as described previously (Stephens et al., 1995) for at
least 7 days prior to use as primary normal rhesus Mf.ing either lymphocytes (CEMx174 cells and normal rhe-
sus macaque peripheral blood lymphocytes) or primary Sheep Mf were obtained and cultured as described pre-
viously (Narayan et al., 1983; Gorrell et al., 1992).normal rhesus macaque macrophages (Mf) as the indi-
cator cell types. We found that while plasmas from some
AntibodiesSIVmac-infected animals failed to neutralize or poorly neu-
tralized the infectivity of SIVmac239 and SIVmac251 (1:20 The source of anti-SIV antibodies used in this study
plasma dilution) in lymphocyte cultures, the same plas- were plasmas collected from rhesus macaques pre-
mas efficiently neutralized these viruses (at high dilu- viously inoculated with SIVmac239 (macaques 1F, 197,
tions) when primary rhesus Mf cultures were used as 262), SIVmac239/17E (macaques M6, M7), or SIVmac251
the indicator cell type. These results indicate fundamen- (macaque 20B) (McEntee et al., 1992; Joag et al., 1994,
tal differences in the way virus infectivity can be neutral- 1995). All plasmas were obtained at approximately 6
ized in these two cell types. months after inoculation with the appropriate strain of
SIVmac . Plasma from a SIV-seronegative normal rhesus
MATERIALS AND METHODS macaque (NRP) was used as control. All plasma samples
were heat-inactivated at 567 for 30 min prior to use inViruses
neutralization assays.
Molecularly cloned virus SIVmac239 and chimeric virus
Purification of IgG from plasmas, papain digestion,SIVmac239/17E have been described previously (Regier and
and purification of the Fab fractionDesrosiers, 1990; Anderson et al., 1993). Both viruses were
obtained by transfecting infectious proviral DNA into The procedure used was similar to a procedure de-
CEMx174 cells and harvesting the culture medium 7 days scribed by Mohanty and Rosenthal (1985) with certain mod-
later. Biologically cloned virus SIVmac251 was obtained by ifications. Briefly, 250 ml of plasma was incubated with 50
passaging virus in CEMx174 cells and harvesting the virus mg of protein A-Sepharose (PAS) for 2 hr at 47. The complex
as above. All virus stocks were stored at 0807 until use. was then washed by centrifugation in phosphate buffer
The infectious titer of virus stocks was measured by the approximately eight times to remove unbound material and
method described before (Joag et al., 1993). the IgG eluted from PAS by glycine–HCl buffer. For purifica-
tion of Fab fragment, papain (Sigma) was added to the
Cells IgG–PAS complex at the final concentration of 0.15 mg/ml
and incubated at 377 for 2 hr. The supernatant fraction,The CEMx174 cell line used in this study is a human
which contained the Fab fragments, was harvested andT–B cell hybrid cell line described previously (Salter et
incubated with PAS again to absorb any contaminating IgGal., 1985). CEMx174 cells were maintained in RPMI 1640
or Fc fragments. The purified Fab fragments were dialyzedmedium supplemented with 10 mM HEPES buffer, 1005 M
against PBS overnight. The purities of IgG and Fab frag-b-mercaptoethanol, 10 mg/ml gentamicin, and 10% fetal
ments were assessed by boiling aliquots in SDS samplebovine serum (R10FBS), and are susceptible to cyto-
buffer (without 2-ME), electrophoresis through 9% SDS–pathic replication of SIVmac239, SIVmac251, and SIVmac239/
PAGE, and visualizing proteins by staining with Coomassie17E (Anderson et al., 1993; Joag et al., 1994). Blood was
brilliant blue. The protein concentrations of the IgG and Fabobtained from SIV-seronegative rhesus macaques, and
fractions were determined using the Bradford techniqueperipheral blood mononuclear cells (PBMC) were sepa-
(Pierce Biochemicals).rated by centrifugation through Ficoll–Hypaque density
gradients. The PBMC were seeded into 35-mm dishes
Virus neutralization assays
at a concentration of 6–8 1 106 cells/dish for 2 hr, in 3
ml of R10FBS. The suspended cells were then removed A standard neutralization assay method was used
when CEMx174 cells or primary normal rhesus PBMCand cultured in R10FBS containing 1 mg/ml PHA for 2
days then maintained in R10FBS with 100 U/ml of rIL-2 were used as the indicator cell type (Joag et al., 1993).
Briefly, serial twofold dilutions of plasma in RPMI 1640(Cetus) and used as source of primary normal rhesus
peripheral blood lymphocytes; the adherent cells in the medium were prepared in quadruplicate in 96-well
plates, 10–100 TCID50 of viruses was added to each well,dishes were replenished with macrophage differentiation
medium (MDM) which consisted of RPMI 1640 with 10% and samples were incubated for 1.5 hr at 377. Following
this incubation, 1 1 104 indicator cells (in 100 ml) werehuman serum, 15% conditioned L-cell medium, 1005 M
b-mercaptoethanol (2-ME), 10 mM HEPES buffer, 5 units/ added to each well and cultured at 377 incubator in 5%
CO2 for 7 days. Cultures were observed daily for develop-ml macrophage colony-stimulating factor (Genetics Insti-
tute), 100 units/ml granulocyte macrophage colony-stim- ment of syncytial cytopathic effects (CPE). To confirm the
results, cultures were washed three times with RPMIulating factor (Genetics Institute), and 10 mg/ml gentami-
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1640 and replenished with R10FBS. After overnight incu- ulated into Mf cultures. At various periods later (0, 3, 6,
and 24 hr), cultures were washed five times with mediumbation, culture media were harvested and analyzed for
the presence or absence of viral p27 using SIV core containing 1 mM EDTA, cell lysates prepared, and viral
proteins immunoprecipitated and analyzed as describedantigen capture assays (Coulter Corp., Miami, FL). For
each assay, a standard curve was prepared according previously (Stephens et al., 1991, 1995). The virus control
used was 35S-SIVmac251 that was heat-inactivated at 567to manufacturer’s instructions, and p27 concentrations
were calculated from the optical density at 450 nm, using for 30 min. Other cell controls included binding of virus–
antibody mixtures to normal sheep Mf cultures whichlinear regression analysis. We found that there was a
perfect correlation between the presence of CPE and the are not permissive for SIVmac infection. Antibody controls
included binding of radiolabeled virus with normal rhe-presence of viral p27 using p27 antigen capture assays.
That is, in the absence of virus neutralization (as evi- sus plasma.
denced by the presence of CPE), viral protein was readily Detection of viral genome using PCR
detected by p27 assays, and vice versa. The 50% neutral-
SIVmac251 virus stock was treated with DNase I for 30ization end point was calculated using the Ka¨rber method
min at 257 and then 10, 1, or 0.1 TCID50 of virus was reacted(Lennette, 1969). Plasma from another SIVmac239-infected with 10 ml of normal, 20B, or M7 plasma in a total volume
macaque, 2D, a rare animal that produced neutralizing
of 100 ml (thus, a 1:10 dilution of plasma) for 1.5 hr at 377.
antibodies against this virus (Joag et al., 1993), was used
Following this incubation, the virus–antibody mixtures were
as a positive control. This serum had a neutralization
inoculated into CEMx174 or Mf cultures. Twenty-four hours
titer of 1:160 against SIVmac239 in both CEMx174 cells postinoculation, cultures were washed five times with RPMI
and PBMC cultures. Plasma from an SIV-seronegative
1640 and the DNA was extracted and used in nested PCR
macaque (NRP) was used as negative control in all the
to detect the presence of the SIV gag gene (Joag et al.,
neutralization assays. 1994b; Stephens et al., 1995). In the first round, SIV oligonu-
For neutralization assays in primary Mf cultures, 10- cleotide primers used were 5*-GATGGGCGTGAGAAACTC-
fold dilutions of plasmas were incubated with 200–1000 CGTCTT-3* and 5*-CCTCCTCTGCCGCTAGATGGTGCTG-
TCID50 of each virus in a volume of 1 ml for 1.5 hr at 377, TTG-3* (noncoding) which are complementary to bases
and the plasma–virus mixtures inoculated into 7-day-old 1052 to 1075 and 1423 to 1450 of the SIVmac239 gag gene,Mf cultures (about 1 1 105 cells/35-mm dish). Dishes respectively (Regier and Desrosiers, 1990). As an internal
were supplemented with 1 ml of additional MDM. Inocu- control, separate PCRs were performed in which the fourth
lated cultures were maintained for 5–7 days at 377. Cul- exon of b-actin was amplified with oligonucleotide primers
tures were then washed three times with RPMI 1640, 5*-TCATGTTTGAGACCTTCAACACCCCAG-5* and 5*-CCA-
replenished with MDM, and incubated overnight. Culture GGAAGGAAGGCTGGAAGAGTGCC-5* (noncoding) com-
media were then harvested and virus neutralization was plementary to the published sequence (Nakijima-Iijima et
determined by measurement of viral p27 levels in the al., 1985). The PCR amplification was performed using the
culture media using SIV core antigen capture assays as following conditions: denaturation at 927 for 1 min, anneal-
described above. ing at 557 for 1 min, and primer extension at 727 for 3 min.
To increase the sensitivity of the reaction, 1 ml of the first
Measurement of virus binding and entry into PCR product was used as a template for a second amplifi-
macrophages cation using the same conditions. The nested SIV primers
used were 5*-GTTGAAGCATGTAGTATGGGCAGC-3* and
To determine if the virus–antibody complexes were 5*-CACCACTAGGTGTCTCTGCACTATCTG-3* (noncoding)
bound to macrophages and were internalized, 35S-la- which are complementary to bases 1142 to 1165 and 1356
beled SIVmac251 (
35S-SIVmac251) was used in a series of to 1382 of SIVmac239, respectively. The nested b-actin prim-
binding assays. Radiolabeled virus was prepared by in- ers used were 5*-CCCCAGCCATGTACGTTGCTATCC-3*
oculating CEMx174 cells with SIVmac251. Seven days and 5*-GCCTCAGGGCAGCGGAACCGCTCA-3* (noncod-
later, infected cells were starved for methionine for 2 ing). Samples were amplified for another 35 cycles as de-
hr in methionine/cysteine-free medium and radiolabeled scribed above. Following the second round of amplification,
with 1 mCi/ml 35S Translabel (ICN) for 18 hr. The radiola- a 10-ml aliquot was removed and run on a 1.5% agarose
beled virus released into the culture medium was har- gel and bands were visualized by staining with ethidium
vested by centrifugation, the amount of infectious virus bromide.
determined by assay in CEMx174 cells, and the amount
RESULTSof p27 determined using SIV core antigen capture
Differential neutralization of SIVmac strains inassay. For binding assays, 200 TCID50 of
35S-SIVmac251
lymphocyte and macrophage culturesin 200 ml was reacted with 10 ml of plasmas or 5 mg of
purified Fab fragments as described in the neutralization We compared the ability of six plasmas from
macaques infected with different strains of SIVmac ,assay above, and the virus–antibody mixtures were inoc-
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TABLE 1
Neutralization of Different Strains of SIVmac with Various Macaque Plasmas Using CEMx174, Normal Macaque PBMC, and Mf Cultures
Virus used in Cell type used in Neutralization titer with various macaque plasmasa
neutralization neutralization
test test 20B 1F 197 262 M6 M7
SIVmac251 CEMx174 1:160 1:20 1:20 1:20 1:20 1:20
PBMC 1:160 1:20 1:20 1:20 1:20 1:20
Mf 1:20,000 1:20,000 1:2,000 1:2,000 1:20,000 1:20,000
SIVmac239 CEMx174 1:20 1:20 1:20 1:20 1:20 1:20
PBMC 1:20 1:20 1:20 1:20 1:20 1:20
Mf 1:200 1:2,000 1:200 1:200 1:2,000 1:2,000
SIVmac239/17E CEMx174 1:80 1:1,280 1:640 1:1,280 1:10,240 1:10,240
PBMC 1:80 1:80 1:80 1:80 1:320 1:320
Mf 1:2,000 1:2,000 1:2,000 1:20,000 1:20,000 1:20,000
a Macaque 20B was infected with SIVmac251; 1F, 197, and 262 were infected with SIVmac239; and M6 and M7 were infected with SIVmac239/17E.
SIVmac239, SIVmac251, and SIVmac239/17E to neutralize The ability of plasmas from SIVmac-infected macaques
to neutralize virus in Mf but not lymphocytesthe same viruses using CEMx174 cell line, PBMC, and
was not related to efficiency of virus replicationMf as the indicator cell types. The results of neutral-
in either cell typeization tests are summarized in Table 1. Similar to
previously reported results (Zhuge et al., 1996), the
The inability of certain plasmas from SIVmac-infectedinfectivity of SIVmac239/17E was neutralized by all six
macaques to neutralize the infectivity of strains of SIVmacplasmas when CEMx174 cells or PBMC were used as
in both types of lymphocyte cultures while efficiently neu-the indicator cell types. In contrast, we found that only
tralizing the infectivity of the same viruses in Mf culturesthe plasma sample derived from an SIVmac251-infected raised the question whether the cultures varied in sus-animal (20B) neutralized SIVmac251 and this had a neu- ceptibility to infection. We examined the replication oftralization titer of 1:160 in both CEMx174 cells and
dual-tropic virus SIVmac251 in CEMx174 cells, PBMC, andPBMC. SIVmac239 was not neutralized by any of the Mf culture. Cultures of each cell type were inoculatedplasmas using CEMx174 cells. One of the plasma
with 100 TCID50 of SIVmac251. Four hours after inocula-samples (from macaque 262) had neutralizing activity
tion, cultures were washed three times with RPMI 1640
at 1:20 dilution using PBMC as indicator cell type.
and replenished with normal culture medium. Virus repli-
A positive control serum from a previously reported
cation was monitored by measurement of amount of viral
animal, 2D, neutralized this virus in CEMx174 cells at
p27 released into culture medium up to 9 days postinfec-
a titer of 1:160.
tion using SIV core antigen capture assays. The results
Neutralization tests were then performed using Mf shown in Fig. 1 indicate that the replication curves of
cultures as indicator cell type. Results revealed that all SIVmac251 in normal macaque Mf, PBMC, and CEMx174three SIVmac strains (SIVmac239, SIVmac251, and SIVmac239/ cells were very similar, suggesting that the differential
17E) were efficiently neutralized by the six plasmas (Ta- neutralization of this virus in the two cell types was not
ble 1). Virus neutralization results in Mf cultures were related to differences in susceptibility of the cells to infec-
obtained using SIV core antigen capture assays. Using tion.
this technique, we found that the neutralization titer of
the plasmas varied from 1:200 to 1:20,000 when Mf were Neutralization in macrophages is not due to Fc
used as the indicator cell type (Table 1). Normal macaque receptor-mediated internalization of virus–antibody
plasma lacking binding antibodies to the virus failed to complexes
neutralize these viruses in Mf cultures. The neutralizing
activities of the antibodies were cross-reactive since the We determined whether virus neutralization in Mf was
antibodies neutralized homologous virus as well as het- related to binding, internalization, and degradation of vi-
erologous viruses in primary Mf cultures (Table 1). rus–antibody complexes via Fc receptors present on the
These results indicated that while some macaque plas- Mf cell surface. To examine the role of Fc receptors,
mas derived from SIVmac-infected animals did not neutral- IgG antibodies were purified from two anti-SIV plasmas,
ize the homologous or heterologous viruses in lympho- M7 and 20B, as well as the normal plasma. Fab’s were
cyte cultures, they efficiently neutralized the same vi- prepared, and the purity of IgG and Fab fractions was
confirmed by Coomassie blue staining following SDS–ruses in Mf cultures.
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FIG. 1. Replication kinetics of SIVmac251 in normal macaque Mf, PBMC, and CEMx174 cultures. Cultures of each cell type were inoculated with
100 TCID50 of SIVmac251. Four hours after inoculation, cultures were washed three times with RPMI 1640 and replenished with normal culture media.
Culture media were collected at 1, 3, 5, 7, and 9 days postinoculation and virus replication was monitored by measurement of amount of viral p27
released into culture media using SIV core antigen capture assays.
PAGE (data not shown). The concentrations of the IgG bated at 377 for various periods (0, 3, 6, and 24 hr). Inocula
were removed and the cultures washed five times withand Fab fractions were determined to be 1.0 and 0.9
mg/ml, respectively. medium containing 1 mM EDTA and then lysed for immu-
noprecipitation analysis. Normal sheep Mf culturesSerial twofold dilutions of purified IgG and Fab (final
concentration of 5, 2.5, 1.25, 0.625, 0.312, and 0.156 were used as nonspecific binding background control.
The results shown in Fig. 3 represent one of three experi-mg/ml) were used for neutralization of 200 TCID50 of
SIVmac251 in Mf cultures as described above. As shown ments in which the purified Fab fractions were used and
cultures were harvested 0, 3, and 6 hr after inoculation.in Fig. 2, both IgG antibodies and Fab fractions purified
from both SIVmac-infected plasmas (20B and M7), but not The results showed that the amount of viral proteins
found in rhesus Mf cell lysates (especially Gag protein)from normal plasma, neutralized the infectivity of
SIVmac251 in Mf cultures at final concentrations of 0.312 were similar despite the presence or absence of neu-
tralizing antibodies. In contrast, the amount of radiola-and 0.625 mg/ml, respectively. Since the purified IgG and
Fab fractions had similar neutralizing activities in Mf beled viral proteins present in sheep Mf lysates was
negligible (lanes 6 and 11), suggesting that the antibod-cultures, these results indicated that neutralization of
SIVmac251 in Mf was not due to the clearance of virus – ies did not prevent the radiolabeled virus from entering
macrophages. Further, immunoprecipitation analyses in-antibody complexes via the Fc receptors on the Mf cell
surface. dicate the presence of the CA (p27) protein band but
gp120 was undetectable compared to controls. The same
results were obtained when the cultures were harvestedNeutralizing antibodies did not prevent the binding
24 hr after inoculation or virus was preincubated withand entry of SIVmac into rhesus macrophages
crude plasmas (data not shown).
A potential mechanism for the observed virus neutral-
ization by these antibodies is that the antibodies pre- The virus entering macrophage cultures in the
vented binding and internalization of virus into Mf. To presence of neutralizing antibodies undergoes
determine whether this occurred, 35S-SIVmac251 was pre- reverse transcription
pared and incubated either with crude plasmas or with
Fab’s from the plasmas for 1.5 hr at 377. Normal plasma The above results suggested that the virus would enter
macrophages in the presence of neutralizing antibodies.was used as negative control. The virus–antibody mix-
tures were added to Mf cultures which were then incu- We determined whether the viral genome was reverse
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FIG. 2. Purified IgG and Fab from SIV-infected macaques have similar neutralizing activities against SIVmac251 in rhesus macrophage cultures.
IgG antibodies were purified from two anti-SIV plasmas (20B and M7) and from normal plasma. Fab’s were prepared as described under Materials
and Methods. For neutralization assays, serial twofold dilutions of purified IgG antibodies and Fab fractions (final concentrations 5, 2.5, 1.25, 0.625,
0.312, and 0.156 mg/ml) were used for neutralizing the infectivities of 200 TCID50 of SIVmac251 in Mf cultures as described under Materials and
Methods. At 7 days postinoculation, culture media were harvested and virus neutralization was determined by measurement of viral p27 levels
using SIV core antigen capture assays. Results were presented as the percentage of virus neutralizing activity determined by calculating the
percentage of reduction of viral p27 released from experimental Mf cultures compared with that from SIVmac251-infected Mf cultures.
transcribed in these cells. DNase-treated SIVmac251 was SIVmac251. However, 20B plasma completely prevented
SIVmac251 infection of CEMx174 cells as evidenced byreacted with various plasmas (at a final dilution of 1:10)
and used to inoculate either rhesus or sheep (as a nega- the lack of a gag PCR product. The finding that plasma
20B, which neutralized SIVmac251 in both Mf andtive control) Mf cultures. At 24 hr, the cultures were
washed extensively and the presence of the viral genome CEMx174 cells, did not prevent infection and reverse
transcription of the viral genome in macrophages butwas determined by nested PCR. All samples were posi-
tive for amplification of the internal control b-actin se- effectively blocked virus entry into CEMx174 cells, em-
phasizes the different mechanism(s) by which antibodyquences (data not shown). As shown in Fig. 4A, 10 or 1
TCID50 of SIVmac251 reacted with normal plasma did not neutralizes infectivity of this virus in these two cell types.
infect sheep Mf cultures, a cell that is not permissive
for this virus infection. In contrast, normal plasma did not Failure of SIVmac to replicate in macrophages was
prevent 10 or 1 TCID50 of virus from entering into rhesus dependent on the continuous presence of anti-SIV
Mf cultures. Incubation of various concentrations of vi- antibodies in the culture medium
rus with immune plasma from macaque 20B (SIVmac251
inoculated) or M7 (SIVmac239/17E inoculated) revealed We determined whether the ‘‘neutralization’’ of SIVmac
in macrophages described above was dependent on thethat these plasmas did not prevent virus entry into rhesus
Mf cultures, and entered virus undergoes reverse tran- continuous presence of antibodies in the culture me-
dium. One hundred TCID50 of SIVmac251 was preincu-scription as evidenced by the ability to amplify gag se-
quences from the DNA prepared from these cultures, bated with a 1:20 dilution of either normal or immune
plasma (from M7) for 1.5 hr at 377 and then inoculatedalthough it appears that the 20B plasma reduced the
infectivity approximately 10-fold when compared with M7 onto Mf cultures which were then incubated at 377 for
24 hr. Cultures were then washed five times with RPMIplasma (Fig. 4A). When the same experiment was per-
formed using CEMx174 cells as the indicator cell type 1640 and then replenished with MDM, with or without
immune plasma, then incubated for up to 17 days. The(Fig. 4B), normal and M7 plasmas, which did not neutral-
ize SIVmac251 in CEMx174 cells (Table 1), did not prevent cultures were examined for viral protein expression at
various time points by SIV core antigen capture assays.infection of this cell type with 10 or 1.0 TCID50 of
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FIG. 3. Neutralization of SIVmac251 in macrophage cultures is not at the step of virus binding and entry. 35S-labeled SIVmac251 was prepared by
radiolabeling SIVmac251-infected CEMx174 cells with [35S]methionine/cysteine (Translabel) for 18 hr. The radiolabeled virus was harvested from the
culture medium by centrifugation, the amount of infectious virus determined by assay in CEMx174 cells, and the amount of p27 determined using
SIV core antigen capture assay. For binding assays, 100–200 TCID50 of 35S-SIVmac251 was reacted with plasmas or purified Fab as described under
Materials and Methods, and the virus–antibody mixtures were used to inoculate Mf cultures. At various periods after inoculation (0, 3, 6, and 24
hr), inocula were removed, cultures were washed five times with medium containing 1 mM EDTA, cell lysates were prepared, and viral proteins
were immunoprecipitated and analyzed as described earlier. The virus control used was 35S-SIVmac251 which was heat-inactivated at 567 for 30
min. Cell controls included binding of virus–antibody mixtures to normal sheep Mf which are not permissive for SIVmac infection. Shown is one of
three experiments in which the purified Fab was used and cultures were harvested 0, 3, and 6 hr after inoculation. The amounts of viral Gag protein
found in rhesus macaque macrophage cell lysates were similar despite the presence or absence of neutralizing antibodies. The same results were
obtained when the cultures were harvested 24 hr after inoculation or the crude plasmas were used as neutralizing antibodies (data not shown). S,
sheep Mf. R, rhesus macaque Mf. M7-Fab, 20B-Fab, and NRP-Fab, Fab fragments purified from M7, 20B, and normal rhesus plasmas, respectively.
HI, heat-inactivated 35S-SIVmac251.
Mf cultures inoculated with virus incubated with normal removal of the antibody, suggesting that this phenome-
non was not due to speculated residual virus in the cul-plasma produced virus-specific p27 after inoculation. In
ture medium. These results supported the above obser-contrast, virus-specific p27 were not detected in Mf cul-
vation that the macrophages had become infected withtures inoculated with the virus–immune plasma mixtures
virus preincubated with ‘‘neutralizing’’ antibody, and fur-and maintained in MDM with immune plasma. Failure to
ther indicated that virus replication was prevented asdetect viral p27 in these media was not due to complexes
long as antibodies were present in the medium. Produc-between virus and antibodies since the antigen was
tive virus replication commenced after the antibodiesreadily detected in preincubated (377/1.5 hr) virus–anti-
were removed.body mixture. However, when Mf cultures inoculated
with the virus–immune plasma mixtures were shifted at
24 or 96 hr postinoculation to MDM without immune DISCUSSION
plasma, viral gene expression resumed, as evidenced
by the presence of virus-specific p27 at subsequent time In this report we show that postinfectious macaque
points after the removal of antibodies (Fig. 5). The kinet- plasma containing anti-SIV antibodies failed to neutralize
ics of p27 production were slightly delayed in the Mf the infectivity of SIVmac in macaque PBMC and a T cell
cultures incubated for 4 days with immune plasma com- line; nevertheless, it inhibited replication of the same
pared to those in which the antibody was removed at 1 virus at high dilutions in macrophage cultures. However,
day postinoculation. However, levels of p27 in the culture true neutralization of the virus did not occur in macro-
phages. Minimal amounts of virus (1 TCID50 per 1000medium plateaued at approximately 7 to 8 days after
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replication in the cells. However, there was considerably
more flexibility in the neutralization of virus in macro-
phages, since antibodies added as long as 24 hr after
virus inoculation still inhibited virus replication in these
cells (McEntee et al., 1992). We extended these observa-
tions in the present study as described above, showing
that antibody-mediated inhibition of virus replication oc-
curred in macrophages even when it did not occur in
lymphocytes. However, the apparent neutralization pro-
cess was really one of interruption of the virus life cycle
by mechanisms that are not understood. A further point
of interest was that this neutralization of virus replication
in macrophages was obtained with heterologous im-
mune sera, whereas neutralization of SIVmac239 and
SIVmac251 in lymphocytes was possible only by homolo-
gous (type-specific) antibodies. The ability of plasmas
FIG. 4. Preincubation of SIVmac251 with immune plasma does not obtained from macaques inoculated with heterologous
inhibit reverse transcription of the viral genome upon entry into rhesus strains of SIVmac to mediate neutralization in macrophage
macrophages. Various concentrations of DNase-I-treated SIVmac251 cultures but not T cell lines or PBMC has not been pre-
(10, 1.0, or 0.1 TCID50) were incubated with normal, 20B, or M7 plasma viously described. In addition, the mechanism(s) involvedfor 1.5 hr at 377 and then used to inoculate either Mf cultures or
in neutralizing viruses in macrophages (characterized byCEMx174 cells. At 24 hr, cultures were washed five times and the DNA
was extracted for PCR analysis as described under Materials and the ability of virus–antibody complexes to enter the tar-
Methods. Inoculation of sheep Mf served as a negative control for the get cell and begin reverse transcription and dependence
inoculum virus. (A) Lanes 1–3, sheep Mf cultures inoculated with 10, on the presence of antibodies in the culture medium) is
1.0, or 0.1 TCID50 of SIVmac251, respectively. Lanes 4–6, rhesus Mf clearly different from those involved in the neutralizationcultures inoculated with various concentrations of SIVmac251 (10, 1.0,
of SIVmac in T lymphocyte cell lines such as CEMx174or 0.1 TCID50) reacted with normal plasma. Lanes 7–9, rhesus Mf
cultures inoculated with various concentrations of SIVmac251 (10, 1.0, cells, since there was no evidence that the T cells had
or 0.1 TCID50) reacted with macaque 20B plasma. Lanes 10–12, rhesus become infected after inoculation with preincubated vi-
Mf cultures inoculated with various concentrations of SIVmac251 (10, rus–antibody complexes as determined by nested PCR.
1.0, or 0.1 TCID50) reacted with macaque M7 plasma. (B) Lane 1, unin- The phenomenon of selective neutralization of virus infected CEMx174 cells. Lanes 2 – 4, CEMx174 cells inoculated with vari-
macrophages may be relevant to two aspects of patho-ous concentrations of SIVmac251 (10, 1.0, or 0.1 TCID50) reacted with
normal plasma. Lanes 5–7, CEMx174 cells inoculated with various genesis of the infection. First, the appearance of these
concentrations of SIVmac251 (10, 1.0, or 0.1 TCID50) reacted with ma- antibodies in plasma may play a role in ending viremia.
caque 20B plasma. Lanes 8–10, CEMx174 cells inoculated with various In a previous report, we had speculated that since the
concentrations of SIVmac251 (10, 1.0, or 0.1 TCID50) reacted with ma- antibodies to SIVmac239, demonstrable by immunoprecip-caque M7 plasma.
itation analyses, did not neutralize this virus in lympho-
cytes, the CMI responses must have been responsible
in toto for ending viremia by killing virus-producing cellsmacrophages) preincubated with various dilutions of
neutralizing plasma at 377 for 1.5 hr, then inoculated onto (Joag et al., 1994a). It is possible that in addition to CMI
responses, the appearance of these antibodies couldmacrophage cultures, was followed by entry of the agent
into the cells, uncoating of the particles, and reverse play as an effector in restricting virus replication in vivo.
This hypothesis could be tested in passive immunizationtranscription of viral RNA to viral DNA. The Fab fraction
of IgG had the same effect as IgG or whole immune experiments in which animals are treated with anti-
SIVmac239 antibodies (which neutralize virus in macro-plasma; thus, the phenomenon was not mediated by Fc
receptor-mediated endocytosis of antibody–virus com- phages but not T cells) and challenged with SIVmac239.
Second, modulation of virus replication in microglia inplexes. As long as antibodies were maintained in the
cultures, no virus proteins were detected in the cells. brain may be regulated by these antibodies that neutral-
ize virus in macrophage cultures by this phenomenon.However, removal of the antibodies from the medium
resulted in resumption of the virus life cycle. Except for locally produced antibodies by plasma cells
that infiltrate the CNS, the blood–brain barrier (BBB) ef-In an earlier report, we had showed that although
SIVmac251 was neutralized by anti-SIVmac251 plasma in fectively restricts ingress of plasma immunoglobulins
into the CNS. However, minimal amounts of IgG (theboth T cells and macrophages, the neutralization in lym-
phocytes required preincubation of virus and antibodies serum/CSF quotient being approximately 400–500; Elo-
vaara et al., 1991; Garton et al., 1991; Meucci et al., 1993)since inoculation of virus into the cells, followed by addi-
tion of antibodies to the medium, did not inhibit virus escaping across the BBB may still be adequate to sup-
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FIG. 5. Continued neutralization of SIVmac251 in macrophages is dependent on the presence of anti-SIV antibodies in the culture medium. SIVmac251
(100 TCID50) was preincubated with a 1:20 dilution of either normal or M7 plasma for 1.5 hr at 377, at which time the virus–antibody mixtures were
used to inoculate rhesus Mf cultures for 24 or 96 hr. The virus inocula were removed and cultures washed five times with medium and then
maintained in MDM in the presence or absence of antibodies for up to 17 days. Cultures were examined for viral protein expression using SIV
core antigen capture assays at the time points indicated. Normal plasma, SIVmac251-infected Mf cultures incubated in the presence of normal
rhesus plasma. Antibody for 1 day, SIVmac251 was preincubated with M7 plasma, and this virus–antibody mixture was used to inoculate Mf cultures
for 24 hr, at which time the cultures were washed and maintained in medium without antibodies for up to 17 days. Antibody for 4 days, SIVmac251
was preincubated with M7 plasma, and this virus–antibody mixture used to inoculate Mf cultures for 96 hr, at which time the cultures were washed
and maintained in medium without antibodies for up to 17 days. Antibody for 17 days, SIVmac251-infected cultures inoculated with virus preincubated
with M7 plasma and maintained in the presence of M7 plasma for up to 17 days.
acquired by SIVmac239 during neuroadaptation in rhesus macaques.press virus replication in brain macrophages because of
Virology 195, 616–626.the high dilutions of plasma that still have inhibitory ef-
Anderson, V. M., and Lee, H. (1995). Lymphocytic interstitial pneumoni-fects on virus replication in these cells. These antibodies
tis in pediatric AIDS. Pediatr. Pathol. 8, 417–421.
however may be lost when levels of antibodies fall in the Burns, D. P., and Desrosiers, R. C. (1994). Envelope sequence variation,
blood, an event that occurs during end-stage AIDS. At neutralizing antibodies, and primate lentivirus persistence. Curr. Top.
Microbiol. Immunol. 188, 185–219.this time, virus replication in microglia in brain could
Desrosiers, R. C. (1990). The simian immunodeficiency viruses. Annu.commence. This correlates with the natural history of SIV
Rev. Immunol. 8, 557–578.encephalitis, since both productive virus replication in
Desrosiers, R. C., Hansen-Moosa, A., Mori, K., Bouvier, D. P., King,macrophages and onset of encephalitis are frequently
N. W., Daniel, M. D., and Ringler, D. J. (1991). Macrophage-tropic vari-
observed as a preterminal phase of the infection or in ants of SIV are associated with specific AIDS related lesions but are
animals (with overwhelming infection) that fail to develop not essential for the development of AIDS. Am. J. Pathol. 139, 29–
35.antibodies as reported earlier (Desrosiers et al., 1991;
Elovaara, I., Seppala, I., Kinnunen, E., and Laaksovirta, H. (1991). In-Narayan et al., 1995; Zhu et al., 1995).
creased occurrence of free immunoglobulin light chains in cerebro-
spinal fluid and serum in human immunodeficiency virus-1 infection.
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